We found that CD4+ cells from severe convalescent patients had significantly higher capacity to produce TNF-α, IL-2 and CD107a at time-point I, compared to healthy controls and mild/moderate COVID-19 convalescents (Supplementary Figure 10A). This evidence concerns the gene IL2 and COVID-19.